Henry C, Semova G, Barnes E, Cotter I, Devers T, Rafaee A
Pediatr Res. 2022; 91(4):735-742.
PMID: 34997225
PMC: 9064797.
DOI: 10.1038/s41390-021-01883-y.
Ohlsson A, Lacy J
Cochrane Database Syst Rev. 2020; 1:CD001239.
PMID: 31995649
PMC: 6988993.
DOI: 10.1002/14651858.CD001239.pub6.
Yang X, Sherwin C, Yu T, Yellepeddi V, Brunner H, Vinks A
Expert Rev Clin Pharmacol. 2015; 8(5):587-603.
PMID: 26143647
PMC: 5575755.
DOI: 10.1586/17512433.2015.1059751.
Alomran A
J Clin Neonatol. 2014; 2(4):163-5.
PMID: 24404526
PMC: 3883209.
DOI: 10.4103/2249-4847.123088.
Alejandria M, Lansang M, Dans L, Mantaring 3rd J
Cochrane Database Syst Rev. 2013; (9):CD001090.
PMID: 24043371
PMC: 6516813.
DOI: 10.1002/14651858.CD001090.pub2.
The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial.
BMC Pregnancy Childbirth. 2008; 8:52.
PMID: 19063731
PMC: 2626572.
DOI: 10.1186/1471-2393-8-52.
Biological response modifiers and infectious diseases: actual and potential therapeutic agents.
Rusthoven J
Int J Antimicrob Agents. 1994; 3(4):223-43.
PMID: 18611565
PMC: 7135342.
DOI: 10.1016/0924-8579(94)90050-7.
Use of intravenous immune globulin in newborn infants.
Fischer G
Clin Exp Immunol. 1994; 97 Suppl 1:73-7.
PMID: 8033439
PMC: 1550380.
Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock.
Pilz G, Werdan K
Infection. 1990; 18(5):253-62.
PMID: 2276817
DOI: 10.1007/BF01646996.
New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.
Hammarstrom L, Smith C
Infection. 1990; 18(5):314-24.
PMID: 2125980
DOI: 10.1007/BF01647018.
Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies.
Fischer G
J Clin Immunol. 1990; 10(6 Suppl):40S-46S.
PMID: 2081788
DOI: 10.1007/BF00918690.
Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trials.
Pilz G, Kaab S, Neeser G, CLASS I, Schweigart U, Brahler A
Infection. 1991; 19(4):216-27.
PMID: 1917032
DOI: 10.1007/BF01644948.
Current status of intravenous immunoglobulin in preventing or treating neonatal bacterial infections.
Weisman L, Cruess D, Fischer G
Clin Rev Allergy. 1992; 10(1-2):13-28.
PMID: 1606520
DOI: 10.1007/978-1-4612-0417-6_2.